İbrahim Celalettin HAZNEDAROĞLU,
Salih AKSU,
Nilgün SAYINALP,
Seyhan TÜRK,
Osama JAVAD,
Can TÜRK,
Elif Sena TEMİRCİ,
Müfide OKAY
The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases
The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases
Turkish Journal of Medical Sciences
2019-Cilt: 49 - Sayı: 2
661-674
86
103